Modulation of G-Protein Coupled Oestrogen Receptor by Boerhavia diffusa

Aims: To investigate the effects of Boerhavia diffusa (B. diffusa) on oestrogen secretion and the expression of cytochrome P450 aromatase (CYP19) and G-protein-coupled oestrogen receptor (GPER) in Michigan Cancer Foundation-7 (MCF-7) cells, including their effects in combination with tamoxifen. Study Design: In vitro experimental study involving phytochemical characterisation of B. diffusa extracts and fractions, followed by the evaluation of oestrogen concentrations in MCF-7 cell culture media and the subsequent analysis of CYP19 and GPER gene expression following combined treatment with B. diffusa and tamoxifen. Place and Duration of Study: The study was conducted at the College of Veterinary and Animal Sciences, Mannuthy, Kerala Veterinary and Animal Sciences University (KVASU), Thrissur, Kerala, India, between December 2021 and November 2024. Methodology: B. diffusa was prepared as a methanolic extract and its solvent fractions and characterised by phytochemical screening and Fourier transform infrared spectroscopy. MCF-7 cells were treated with concentrations corresponding to half IC₅₀, IC₅₀ and double IC₅₀ of B. diffusa and tamoxifen. Oestrogen concentrations in culture media were determined by radioimmunoassay after 48 and 96 h. The relative expression of CYP19 and GPER following combined treatment with B. diffusa and tamoxifen was evaluated using quantitative real-time PCR. Results: Phytochemical analysis of B. diffusa revealed the presence of bioactive constituents, with functional groups confirmed by FTIR. Treatment with B. diffusa extract and its fractions reduced oestrogen concentrations in MCF-7 cell culture media compared with untreated controls, with a pronounced reduction observed after 96 h. The combination of the hexane fraction of B. diffusa and tamoxifen resulted in the lowest relative expression of CYP19 (0.02-fold) and GPER (0.26-fold) among the treatment groups. Conclusion: B. diffusa inhibits MCF-7 cell proliferation and modulates GPER-mediated oestrogen signalling. This study highlights the potential of B. diffusa and its solvent fractions as sources of bioactive compounds capable of modulating GPER-related signalling, supporting further research into their possible application as complementary agents in hormone-dependent breast cancer.

Authors

Institutions

Publication Details

Journal
Journal of Advances in Biology & Biotechnology
Published
2026-11-14
DOI
https://doi.org/10.9734/jabb/2026/v29i114683
Primary Topic
Estrogen and related hormone effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Modulation of G-Protein Coupled Oestrogen Receptor by Boerhavia diffusa

Nisaath Begum, Preethy John, Dhanush Krishna, VJ. Krishnanjana et al.
Journal of Advances in Biology & Biotechnology
Estrogen and related hormone effects
article

Modulation of G-Protein Coupled Oestrogen Receptor by Boerhavia diffusa

Nisaath Begum, Preethy John, Dhanush Krishna, VJ. Krishnanjana, AR. Nisha, S. Sujith, R. Uma
article en

Abstract

Aims: To investigate the effects of Boerhavia diffusa (B. diffusa) on oestrogen secretion and the expression of cytochrome P450 aromatase (CYP19) and G-protein-coupled oestrogen receptor (GPER) in Michigan Cancer Foundation-7 (MCF-7) cells, including their effects in combination with tamoxifen. Study Design: In vitro experimental study involving phytochemical characterisation of B. diffusa extracts and fractions, followed by the evaluation of oestrogen concentrations in MCF-7 cell culture media and the subsequent analysis of CYP19 and GPER gene expression following combined treatment with B. diffusa and tamoxifen. Place and Duration of Study: The study was conducted at the College of Veterinary and Animal Sciences, Mannuthy, Kerala Veterinary and Animal Sciences University (KVASU), Thrissur, Kerala, India, between December 2021 and November 2024. Methodology: B. diffusa was prepared as a methanolic extract and its solvent fractions and characterised by phytochemical screening and Fourier transform infrared spectroscopy. MCF-7 cells were treated with concentrations corresponding to half IC₅₀, IC₅₀ and double IC₅₀ of B. diffusa and tamoxifen. Oestrogen concentrations in culture media were determined by radioimmunoassay after 48 and 96 h. The relative expression of CYP19 and GPER following combined treatment with B. diffusa and tamoxifen was evaluated using quantitative real-time PCR. Results: Phytochemical analysis of B. diffusa revealed the presence of bioactive constituents, with functional groups confirmed by FTIR. Treatment with B. diffusa extract and its fractions reduced oestrogen concentrations in MCF-7 cell culture media compared with untreated controls, with a pronounced reduction observed after 96 h. The combination of the hexane fraction of B. diffusa and tamoxifen resulted in the lowest relative expression of CYP19 (0.02-fold) and GPER (0.26-fold) among the treatment groups. Conclusion: B. diffusa inhibits MCF-7 cell proliferation and modulates GPER-mediated oestrogen signalling. This study highlights the potential of B. diffusa and its solvent fractions as sources of bioactive compounds capable of modulating GPER-related signalling, supporting further research into their possible application as complementary agents in hormone-dependent breast cancer.

Journal of Advances in Biology & BiotechnologyVol. 29(11)
Kerala Veterinary and Animal Sciences University (IN)
Estrogen and related hormone effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon